588 related articles for article (PubMed ID: 8721905)
1. Hepatocyte growth factor and acute phase proteins in patients with chronic liver diseases.
Shiota G; Umeki K; Okano J; Kawasaki H
J Med; 1995; 26(5-6):295-308. PubMed ID: 8721905
[TBL] [Abstract][Full Text] [Related]
2. Serum hepatocyte growth factor levels in liver diseases: clinical implications.
Shiota G; Okano J; Kawasaki H; Kawamoto T; Nakamura T
Hepatology; 1995 Jan; 21(1):106-12. PubMed ID: 7806142
[TBL] [Abstract][Full Text] [Related]
3. Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C-viral chronic liver diseases.
Yamagamim H; Moriyama M; Matsumura H; Aoki H; Shimizu T; Saito T; Kaneko M; Shioda A; Tanaka N; Arakawa Y
Cancer; 2002 Aug; 95(4):824-34. PubMed ID: 12209727
[TBL] [Abstract][Full Text] [Related]
4. Association between serum hepatocyte growth factor and survival in untreated hepatocellular carcinoma.
Vejchapipat P; Tangkijvanich P; Theamboonlers A; Chongsrisawat V; Chittmittrapap S; Poovorawan Y
J Gastroenterol; 2004 Dec; 39(12):1182-8. PubMed ID: 15622483
[TBL] [Abstract][Full Text] [Related]
5. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of serum hepatocyte growth factor levels in liver diseases.
Hioki O; Watanabe A; Minemura M; Tsuchida T
J Med; 1993; 24(1):35-46. PubMed ID: 7684768
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma.
Hsia CY; Huo TI; Chiang SY; Lu MF; Sun CL; Wu JC; Lee PC; Chi CW; Lui WY; Lee SD
Eur J Surg Oncol; 2007 Mar; 33(2):208-12. PubMed ID: 17140760
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of acute phase proteins in patients with nonalcoholic steatohepatitis.
Koruk M; Tayşi S; Savaş MC; Yilmaz O; Akçay F; Karakök M
Turk J Gastroenterol; 2003 Mar; 14(1):12-7. PubMed ID: 14593532
[TBL] [Abstract][Full Text] [Related]
9. Portal and systemic serum growth factor and acute-phase response after laparotomy or partial hepatectomy in patients with colorectal liver metastases: a prognostic role for C-reactive protein and hepatocyte growth factor.
de Jong KP; Hoedemakers RM; Fidler V; Bijzet J; Limburg PC; Peeters PM; de Vries EG; Slooff MJ
Scand J Gastroenterol; 2004 Nov; 39(11):1141-8. PubMed ID: 15545174
[TBL] [Abstract][Full Text] [Related]
10. Serum hepatocyte growth factor before and after resection for hepatocellular carcinoma.
Hu RH; Lee PH; Yu SC; Sheu JC; Lai MY
Hepatogastroenterology; 1999; 46(27):1842-7. PubMed ID: 10430357
[TBL] [Abstract][Full Text] [Related]
11. Significance of serum hepatocyte growth factor levels in patients with hepatocellular carcinoma undergoing hepatic resection.
Chau GY; Lui WY; Chi CW; Chau YP; Li AF; Kao HL; Wu CW
Eur J Surg Oncol; 2008 Mar; 34(3):333-8. PubMed ID: 17218078
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor (HGF) in patients with hepatitis B and meningitis.
Ozden M; Kalkan A; Demirdag K; Denk A; Kilic SS
J Infect; 2004 Oct; 49(3):229-35. PubMed ID: 15337340
[TBL] [Abstract][Full Text] [Related]
13. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI
Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863
[TBL] [Abstract][Full Text] [Related]
14. Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma.
Hayasaka A; Suzuki N; Fujimoto N; Iwama S; Fukuyama E; Kanda Y; Saisho H
Hepatology; 1996 Nov; 24(5):1058-62. PubMed ID: 8903375
[TBL] [Abstract][Full Text] [Related]
15. Human interleukin 6 gene is activated by hepatitis B virus-X protein in human hepatoma cells.
Lee Y; Park US; Choi I; Yoon SK; Park YM; Lee YI
Clin Cancer Res; 1998 Jul; 4(7):1711-7. PubMed ID: 9676846
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor beta1 and soluble Fas serum levels in hepatocellular carcinoma.
Sacco R; Leuci D; Tortorella C; Fiore G; Marinosci F; Schiraldi O; Antonaci S
Cytokine; 2000 Jun; 12(6):811-4. PubMed ID: 10843770
[TBL] [Abstract][Full Text] [Related]
17. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
18. Implications of serum basic fibroblast growth factor levels in chronic liver diseases and hepatocellular carcinoma.
Hsu PI; Chow NH; Lai KH; Yang HB; Chan SH; Lin XZ; Cheng JS; Huang JS; Ger LP; Huang SM; Yen MY; Yang YF
Anticancer Res; 1997; 17(4A):2803-9. PubMed ID: 9252719
[TBL] [Abstract][Full Text] [Related]
19. Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance.
Fujimoto M; Uemura M; Nakatani Y; Tsujita S; Hoppo K; Tamagawa T; Kitano H; Kikukawa M; Ann T; Ishii Y; Kojima H; Sakurai S; Tanaka R; Namisaki T; Noguchi R; Higashino T; Kikuchi E; Nishimura K; Takaya A; Fukui H
Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):48S-54S. PubMed ID: 10803780
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
Ishii M; Gama H; Chida N; Ueno Y; Shinzawa H; Takagi T; Toyota T; Takahashi T; Kasukawa R
Am J Gastroenterol; 2000 Apr; 95(4):1036-40. PubMed ID: 10763956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]